General
Preferred name
TALADEGIB
Synonyms
LY2940680 ()
LY 2940680 ()
Taladegib hydrochloride ()
Taladegib (LY2940680) ()
LY-2940680 ()
P&D ID
PD012766
CAS
1258861-20-9
Tags
available
drug candidate
Drug indication
Solid tumour/cancer
Ovarian cancer
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Taladegib (LY2940680; Eli Lilly/Endeavor Biomedicines) is an orally active SMO antagonist that was developed as an antitumour agent .
(GtoPdb)
DESCRIPTION
Taladegib is an inhibitor of Smoothened (Smo) receptor and potently inhibits Hedgehog (Hh) signaling. It inhibits cell growth and proliferation in tumor cell lines.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
2
Organisms
0
Compound Sets
16
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
JUMP-Target 1 Compound Set
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
26
Molecular Weight
512.19
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
5
Aromatic Ring Count
4
cLogP
4.93
TPSA
67.15
Fraction CSP3
0.31
Chiral centers
0.0
Largest ring
6.0
QED
0.36
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Stem Cells
Stem Cell/Wnt
Target
Smoothened
DHH, IHH, SMO
SMO antagonist
DHH
SMO
Hedgehog/Smoothened
MOA
Hedgehog/Smoothened antagonist
Smoothened receptor antagonist
Source data